"Gilead is an acquisition style companies owning many smaller pharmaceutical companies. I think they bought Remdesivir."
Remdesivir was originally created and developed by Gilead Sciences in 2009, to treat hepatitis C and respiratory syncytial virus (RSV). https://en.wikipedia.org/wiki/Remdesivir
"The way it looks to me is: They are probably having very private talks with Leo and company. So don’t be surprised. There are too many coincidences here. Gilead has a very expensive board to please. They probably have to wait on phase 2 complete before it can go forward corporately. "
You can bet on it! To not engage Leo in discussions would be a failure of fiduciary responsibilities.